said Friday it has reached a settlement with two plaintiffs in Ohio in the federal litigation over opioids. The Dublin-based company said it will pay $1.9 million to Summit county, Ohio and $3.1 million to Cuyahoga County, Ohio to resolve all claims that were to have been part of a trial scheduled for October. “The company believes that settling with these plaintiffs is in its interest in light of anticipated time and defense costs for this first multi-defendant bellwether trial in the federal multidistrict litigation,” Allergan said in a statement. The company does not have liability for generic claims, it added, as those assets were sold to Teva
in 2016. Allergan has not promoted or marketed any opioid products since 2013, it said. Shares were not yet active premarket, but have gained 19.5% in 2019, while the S&P 500
has gained 16.6%.
Go to Source